Cell proliferation and apoptosis in normal liver and preneoplastic foci.
- 1 December 1993
- journal article
- review article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 101 (suppl 5), 87-90
- https://doi.org/10.1289/ehp.93101s587
Abstract
The growth rate of tissues including tumors is determined by the difference between cell replication and cell death. Among different types of cell death, apoptosis, a form of programmed cell death, is of particular importance. Nongenotoxic carcinogens exert their carcinogenic effects not only via stimulation of cell replication but also by modulating the incidence of apoptosis. This can be seen at different stages of carcinogenesis: a) After initiation in the liver, many initiated cells may undergo apoptosis and never develop into preneoplastic foci, as suggested by both biological and mathematical studies. Thus, apoptosis appears to determine the efficiency of initiation. b) In the promotion stage, early preneoplastic hepatic foci originate either from treatment with a genotoxic carcinogen or spontaneously exhibit much higher rates of cell replication than normal cells, but nevertheless show little preferential growth. This is due to enhanced rates of apoptosis. Some tumor promoters were found to inhibit apoptosis and thereby accelerate foci growth and carcinogenesis. c) In neoplastic nodules and tumors, apoptosis has been shown to be an important growth determinant and to be regulated by growth regulatory hormones, which thereby may decrease or accelerate tumor growth. Studies on the regulation of apoptosis revealed that in the liver, transforming growth factor TGF-beta 1 is involved in the initiation of apoptosis. This was based on three lines of evidence: TGF-beta 1 induced apoptosis in isolated hepatocytes, b) in vivo hepatocytes undergoing apoptosis showed positive immunostaining with antibodies against a precursor of TGF-beta 1.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 30 references indexed in Scilit:
- Hepatocyte proliferation in stepwise development of experimental liver cell cancerDigestive Diseases and Sciences, 1991
- Cell proliferation and promotion of rat liver carcinogenesis: different effect of hepatic regeneration and mitogen induced hyperplasia on the development of enzyme-altered fociCarcinogenesis: Integrative Cancer Research, 1990
- Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments—I. Single agent regimenCarcinogenesis: Integrative Cancer Research, 1990
- Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of γ-glutamyl transferase as markers of altered foci during liver carcinogenesis in ratsCarcinogenesis: Integrative Cancer Research, 1985
- Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promotersCarcinogenesis: Integrative Cancer Research, 1984
- Antagonistic effect of androgen on prostatic cell deathThe Prostate, 1984
- Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to HumansCRC Critical Reviews in Toxicology, 1983
- The stages of initiation and promotion in hepatocarcinogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1980
- Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activationNature, 1980